|
Home
Search
Study Topics
Glossary
|
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
![]() |
||||||||||||||||||||||||||||||||||||
| Sponsor: | National Cancer Institute (NCI) |
|---|---|
| Information provided by: | National Cancer Institute (NCI) |
| ClinicalTrials.gov Identifier: | NCT00378846 |
Purpose
RATIONALE: Comparing results of three different thermometers used to measure body temperature may help doctors find the most accurate thermometer to detect fever and plan the best treatment.
PURPOSE: This clinical trial is studying three different types of thermometers to measure temperature in young patients with fever and without fever.
| Condition | Intervention |
|---|---|
|
Fever, Sweats, and Hot Flashes |
Procedure: infrared thermography |
| Study Type: | Interventional |
| Study Design: | Primary Purpose: Diagnostic |
| Official Title: | A Study Evaluating the Agreement of Devices for Measuring Temperature in Children |
| Estimated Enrollment: | 32 |
| Study Start Date: | March 2006 |
| Primary Completion Date: | November 2009 (Final data collection date for primary outcome measure) |
OBJECTIVES:
Primary
Secondary
OUTLINE: This is a prospective study.
During an afebrile episode, the patient's temperature is measured twice using the following 3 devices: a temporal artery scanner, a digital oral thermometer, and an infrared tympanic thermometer calibrated to an oral setting (total of 6 temperature measurements per afebrile episode).
During a febrile episode, the patient's temperature is measured twice using all 3 devices as above, and then at 2 and 4 hours after administration of an antipyretic medication (total of 18 temperatures per febrile episode).
Patients' temperatures are recorded for a maximum of 3 afebrile or febrile episodes.
PROJECTED ACCRUAL: A total of 32 patients will be accrued for this study.
Eligibility| Ages Eligible for Study: | 4 Years to 17 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
DISEASE CHARACTERISTICS:
Patient at the Mark O. Harfield Clinical Research Center
PATIENT CHARACTERISTICS:
PRIOR CONCURRENT THERAPY:
Contacts and Locations| United States, Maryland | |
| Warren Grant Magnuson Clinical Center - NCI Clinical Trials Referral Office | |
| Bethesda, Maryland, United States, 20892-1182 | |
| Principal Investigator: | Thomas J. Walsh, MD | NCI - Pediatric Oncology Branch |
More Information
| ClinicalTrials.gov Identifier: | NCT00378846 History of Changes |
| Other Study ID Numbers: | CDR0000496917, NCI-06-C-0118, NCI-P6842 |
| Study First Received: | September 19, 2006 |
| Last Updated: | November 26, 2009 |
| Health Authority: | United States: Federal Government |
|
fever, sweats, and hot flashes |
|
Fever Hot Flashes Body Temperature Changes Signs and Symptoms |